Antibody therapies Flashcards
Target cell surface antigens
BARNT: Basiliximab (anti IL2R aka CD25) Abatacept (anti-CTLA4-Ig; CTLA4/CD25 T cell + CD80/86 B cell system) Rituximab (anti-CD20) Natalizumab (anti-integrinalpha4) Tocilizumab (anti-IL6R)
Target cytokines
Infliximab, Adalimumab, Certolizumab, Golimumab (anti-TNFalpha) Etanercept (anti-TNF) Ustekinumab (anti-IL12 + 23) Guselkumab (anti-IL23) Secukinumab (anti-IL17) Denosumab (anti-RANKL)
Inhibit calcineurin - IL-2 - T cell proliferation
CycT:
Calcineurin inhibitors:
Cyclosporin
Tacrolimus
JAK inhibitor
Tofacitinib
Jack is a right toff
PDE4 inhibitor
Apremilast
Pride after a fall
Basiliximab
anti-IL2R (CD25)
Harry Potter 2 = basilisk
Abatacept
(anti-CTLA4)
Ig fusion protein
CTLA4/CD25 T cell + CD80/86 B cell system
‘Looking for abata system’
Rituximab
anti-CD20
Tu Xs
Natalixumab
anti-integrin alpha 4
‘Natalixing you through’
Tocilizumab
anti-IL6R
Tick tock its 6 o clock
Infliximab
anti-TNFalpha
Alpha inflicts pain in the library
Adalibumab
anti-TNFalpha
Alpha inflicts pain in the library
Etanercept
anti-TNF (alpha + beta)
A tonne of TNF
Ustekinumab
anti-IL12 + IL23
U stick 12 and 23 together
Guselkumab
anti-IL23
23 Guseled 12